Brief: Opthea Ltd Announces Decision To Discontinue Wet AMD Trials
31/03/2025 09:34
March 31 (Reuters) - Opthea Ltd OPT.AX: ANNOUNCES DECISION TO DISCONTINUE WET AMD TRIALS CONTINUES ACTIVE DISCUSSIONS WITH DFA INVESTORS ESTIMATES WILL HAVE UNAUDITED CASH AND CASH EQUIVALENTS OF US$100M AT END OF MARCH 2025 THERE REMAINS MATERIAL UNCERTAINTY AS TO OPTHEA'S ABILITY TO CONTINUE AS A GOING CONCERN Further company coverage: OPT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Opthea
See all newsBrief: Opthea To Recommence Trading On ASX On Or Around June 3, 2026
Brief: Opthea Says Hamish George Assumes Role Of CFO
Brief: Opthea Logs FY Prelim Loss Attributable $162.8 Mln
Australia's Opthea cuts 80% staff, key executives to exit in deal to avert bankruptcy (updated)
Brief: Opthea Says CEO Fred Guerard To Step Down